Skip to main content

Table 1 Human iPSCs generated from PB with the optimized protocol

From: Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood

Sample number Genetic background Age (years) Male/female Efficiency (%) Number of iPSC linesa
PB-1 Normal 39 Female 0.0004 4
PB-2 Normal 26 Female 0.001 5
PB-3 Normal 34 Female 0.002 8
PB-4 Normal 45 Female 0.002 13
PB-5 Normal 23 Female 0.0002 3
PB-6 Normal 20 Male 0.00053 12
PB-7 Normal 26 Male 0.0007 2
PB-8 Normal 47 Male 0.00253 1
PB-9 Normal 11 Male 0.0006 5
PB-10 Normal 59 Male 0.0009 3
PB-11 Normal 36 Male 0.00657 5
PB-12 Normal 10 Male 0.00387 8
PB-13 Normal 3 Male 0.001 3
PB-14 Normal 4 Male 0.0006 5
PB-15 Normal 28 Female 0.002 2
PB-16 Normal 24 Female 0.001 3
PB-17 Normal 26 Female 0.005 5
PB-18 Normal 24 Male 0.009 10
PB-19 Normal 23 Female 0.002 4
PB-20 Normal 20 Male 0.001 3
PB-21 Normal 24 Female 0.0008 7
PB-22 PRV 22 Male 0.00193 9
PB-23 PRV 22 Male 0.00243 9
PB-24 JMML 3 Male 0.0006 1
PB-25 JMML 3.9 Male 0.0008 2
PB-26 JMML 5 Male 0.00114 10
  1. iPSC induced pluripotent stem cell, JMML juvenile myelomonocytic leukemia, PB peripheral blood, PRV polycythemia vera
  2. aiPSC lines listed were identified by ESC characterization. We did not include iPSC lines without identification in the analysis